STOCK TITAN

Societal CDMO Inc - SCTL STOCK NEWS

Welcome to our dedicated news page for Societal CDMO (Ticker: SCTL), a resource for investors and traders seeking the latest updates and insights on Societal CDMO.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Societal CDMO's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Societal CDMO's position in the market.

Rhea-AI Summary
Societal CDMO, Inc. closed its underwritten public offering, raising $8.3 million for general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.24%
Tags
-
Rhea-AI Summary
Societal CDMO, Inc. announced the pricing of its underwritten public offering of 20,750,000 shares of common stock at $0.40 per share, with gross proceeds of $8.3 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.88%
Tags
-
Rhea-AI Summary
Societal CDMO, Inc. is commencing an underwritten public offering of its common stock, subject to market conditions. Craig-Hallum Capital Group LLC is the sole managing underwriter for the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.88%
Tags
Rhea-AI Summary
Societal CDMO appoints Matt Arens to board of directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.88%
Tags
management
-
Rhea-AI Summary
Societal CDMO, Inc. reported Q2 revenue of $21.8 million, signed new business agreements, and secured a Schedule 1 Controlled Substance Manufacturing License. EBITDA guidance revised to $12-15 million. Q2 net loss of $3.2 million. Revenue for six months ended June 30, 2023, was $43.3 million. EBITDA for six months was $3.4 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.59%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.99%
Tags
Rhea-AI Summary
Societal CDMO, Inc. (SCTL) Announces Q2 2023 Financial Results Webcast and Operational Highlights
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
none
-
Rhea-AI Summary
Societal CDMO, a contract development and manufacturing organization, has announced the addition of new employees to fill open roles. Inducement stock option grants were approved for the new hires, totaling 54,910 shares of the company's common stock. The grants were made as part of each employee's compensation and will vest over four years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Societal CDMO Inc

Nasdaq:SCTL

SCTL Rankings

SCTL Stock Data

116.13M
53.02M
45.32%
57.56%
0.26%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States
Exton

About SCTL

recro gainesville, llc, provides solid dosage form development, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market. specializing in extended release solid dose and dea controlled substances, recro has the experts to deliver clients’ most complex pharmaceutical development and manufacturing projects in its best-in-class, 97,000-square-foot manufacturing facility. for more information about recro’s flexible cdmo solutions, visit www.recrogainesville.com